CME Group Inc. (CME) Shares Bought by Pacer Advisors Inc.
Pacer Advisors Inc. lifted its holdings in CME Group Inc. (NASDAQ:CME) by 14.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,441 shares of the financial services provider’s stock after buying an additional 932 shares during the quarter. Pacer Advisors Inc.’s holdings in CME Group were worth $1,010,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. ST Germain D J Co. Inc. bought a new stake in CME Group during the 3rd quarter worth about $232,000. Capital Advisors Inc. OK raised its holdings in CME Group by 10.7% during the 2nd quarter. Capital Advisors Inc. OK now owns 84,533 shares of the financial services provider’s stock worth $10,587,000 after purchasing an additional 8,198 shares during the last quarter. Marvin & Palmer Associates Inc. raised its holdings in CME Group by 100.7% during the 2nd quarter. Marvin & Palmer Associates Inc. now owns 57,278 shares of the financial services provider’s stock worth $7,173,000 after purchasing an additional 28,745 shares during the last quarter. Captrust Financial Advisors bought a new stake in CME Group during the 2nd quarter worth about $693,000. Finally, Commerce Bank raised its holdings in CME Group by 3.8% during the 2nd quarter. Commerce Bank now owns 560,899 shares of the financial services provider’s stock worth $70,247,000 after purchasing an additional 20,449 shares during the last quarter. 82.58% of the stock is owned by institutional investors and hedge funds.
In related news, Director Daniel R. Glickman sold 850 shares of the business’s stock in a transaction that occurred on Monday, August 28th. The stock was sold at an average price of $126.65, for a total value of $107,652.50. Following the completion of the transaction, the director now directly owns 13,799 shares in the company, valued at approximately $1,747,643.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John W. Pietrowicz sold 5,175 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total value of $722,947.50. The disclosure for this sale can be found here. Insiders have sold a total of 13,939 shares of company stock valued at $1,910,968 over the last 90 days. Corporate insiders own 0.57% of the company’s stock.
CME Group Inc. (CME) opened at $141.87 on Friday. The stock has a market capitalization of $48,110.24, a PE ratio of 29.68, a PEG ratio of 2.91 and a beta of 0.71. CME Group Inc. has a 12-month low of $111.19 and a 12-month high of $143.99. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11.
CME Group (NASDAQ:CME) last posted its earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The company had revenue of $890.80 million during the quarter, compared to analyst estimates of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.05 EPS. equities research analysts predict that CME Group Inc. will post 4.78 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Friday, December 8th will be given a dividend of $0.66 per share. The ex-dividend date is Thursday, December 7th. This represents a $2.64 annualized dividend and a dividend yield of 1.86%. CME Group’s payout ratio is currently 59.86%.
CME has been the subject of several recent research reports. Barclays PLC initiated coverage on CME Group in a report on Friday, September 8th. They set an “overweight” rating and a $139.00 price objective for the company. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a report on Friday, September 1st. UBS Group AG reissued a “buy” rating and set a $135.00 price objective (up from $134.00) on shares of CME Group in a report on Wednesday, September 6th. Citigroup Inc. boosted their price objective on CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, October 19th. Finally, Wells Fargo & Co boosted their price objective on CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and seven have given a buy rating to the company. CME Group currently has an average rating of “Buy” and a consensus price target of $141.75.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.